Ausgabe 3/1999
Inhalt (12 Artikel)
Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice
Vernon Knight, Nadezhda V. Koshkina, J. Clifford Waldrep, Beppino C. Giovanella, Brain E. Gilbert
Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant
Quincy Chau, David J. Stewart
Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice
Nadezhda V. Koshkina, Brain E. Gilbert, J. Clifford Waldrep, Alexander Seryshev, Vernon Knight
Vincristine pharmacokinetics after repetitive dosing in children
C. E. M. Gidding, G. J. Meeuwsen-de Boer, P. Koopmans, D. R. A. Uges, W. A. Kamps, S. S. N. de Graaf
Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status
Raoul Borbé, Johannes Rieger, Michael Weller
Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas
P. Beauchesne, C. Soler, P. Rusch, M. J. Fotso, R. Duthel, T. Schmitt, J. Brunon
Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines
Michael J. Kelner, Trevor C. McMorris, Mark A. Montoya, Leita Estes, Sheldon F. Uglik, Mary Rutherford, Kyra M. Samson, Richard D. Bagnell, Raymond Taetle
Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment
Ian Knemeyer, M. Guillaume Wientjes, Jessie L.-S. Au
Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule
James P. Stevenson, Deborah DeMaria, Denise Reilly, Joseph D. Purvis, Martin A. Graham, Graham Lockwood, Marion Drozd, Peter J. O'Dwyer
Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells
Teresa L. Fuller, Robert G. Canada
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel
S. Aebi, T. W. Schnider, G. Los, D. D. Heath, D. Darrah, S. Kirmani, E. F. McClay, H. D'Agostino, S. C. Plaxe, D. Fink, M. M. De las Alas, S. B. Howell, R. D. Christen
A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy
C. G. Alexopoulos, G. Rigatos, A. P. Efremidis, A. Papacharalambous, A. Alexopoulos, M. Vassilomanolakis, E. Patila